about
Bringing memory fMRI to the clinic: comparison of seven memory fMRI protocols in temporal lobe epilepsyEpilepsy: recent advances.Neurological disorders.The effect of depression and side effects of antiepileptic drugs on injuries in patients with epilepsy.Fatigue during treatment with antiepileptic drugs: A levetiracetam-specific adverse event?Mononeuritis multiplex: association with infectious condition and familial background in a tropical environment: a case report.Effective cerebrovascular thrombectomy requires well-organized structures : Real world experiences of a regional stroke network between 2012-2015.Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.Depression correlates with quality of life in people with epilepsy independent of the measures used.Digital photography and 3D MRI-based multimodal imaging for individualized planning of resective neocortical epilepsy surgery.Clinical correlates of memory complaints during AED treatment.Screening of anxiety and quality of life in people with epilepsy.Screening for depression in epilepsy: a model of an enhanced screening tool.Correlation of hippocampal glucose oxidation capacity and interictal FDG-PET in temporal lobe epilepsy.Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy.Which symptoms are indicative of depression in epilepsy settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms.Change of pitch due to carbamazepine and oxcarbazepine independently.Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series.CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery.Neuronal substrates of sensory gating within the human brain.Self-reported aggressiveness during treatment with levetiracetam correlates with depression.Selective middle cerebral artery Wada tests as a part of presurgical evaluation in patients with drug-resistant epilepsies.Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods.Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome.Selective lesion to the entorhinal cortex leads to an impairment in familiarity but not recollection.Limbic system abnormalities associated with Ammon's horn sclerosis do not alter seizure outcome after amygdalohippocampectomy.PET and ictal SPECT can be helpful for localizing epileptic foci.Left entorhinal cortex and object recognition.MR imaging in the presurgical workup of patients with drug-resistant epilepsy.Evaluation of Clinical and Paraclinical Findings for the Differential Diagnosis of Autoimmune and Infectious Encephalitis.Déjà vu and the entorhinal cortex: dissociating recollective from familiarity disruptions in a single case patientProspective use of subtraction ictal SPECT coregistered to MRI (SISCOM) in presurgical evaluation of epilepsyBCIs for DOC Patients: Assessment, Communication, and New DirectionsIncreased laminin A expression in regenerating myofibers in neuromuscular disordersCardiac asystole in epilepsy: clinical and neurophysiologic featuresLevetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination
P50
Q36866305-C9004828-1ACF-4677-9143-4DFEC78CB909Q37792844-ECF9813C-7314-4105-93BC-CB6DEA72FD10Q38132498-773EFE74-8297-4A80-BC82-754A2A949D1EQ38670342-F0FFC790-E1D6-49F1-A9E6-11DAA80D2E7BQ38750672-440A0ACA-173F-4E3A-84C6-9A7D7188E88AQ38927925-F4BB6E4E-F756-4AE6-B8E1-61ED4FE61722Q39008755-E0DA5394-E3FB-45DB-ACC2-19A907B3AD91Q39244763-A66197D8-2719-4257-BE8B-9EFA804BD62EQ39508230-0D507EBF-75CC-451A-88CB-C54B3D72CF8CQ39636856-21F16243-EE88-4F6C-8BE2-D893F03BC599Q40117991-73F125FE-930C-43E0-A6E7-AC0167121A5CQ40421002-DAB22B2C-7E2B-4A92-B0EE-D19DAFBA8D97Q41520591-74F32A0A-7FA3-4A8A-810C-F9F18B00F99AQ42436437-821AD758-4F6F-4E8F-8405-854A781B1BA7Q43551996-5C591664-E0A3-4269-8797-A8F9D02E3C16Q43974125-F17AB21E-A43B-4DAB-8B59-35A78FED766AQ45784463-5DAE78C0-CCBB-4B22-9C58-E390AF4C8A5AQ46969402-D1BD083C-0A11-4CED-8E77-2D2EF0FF567AQ47581475-87666999-90F0-48A7-94AE-64688BABE864Q47639772-21E11F5E-3BDF-4770-BD48-275AE45D53C7Q48027254-15D18094-B07D-4BA2-9064-83B588AF2D92Q48086350-983B820A-DA2B-4B41-A71E-76C073666B5BQ48474565-15413338-0737-4F72-8456-1C3C3A54F468Q48650045-40548D02-9214-4C4F-898E-8FD43BE97368Q48669493-FF5FFEDE-1E4D-4E12-A63F-2274E41F8526Q48832766-20471272-73C1-4910-8C43-B03A5A0EA8FAQ48938883-6ABA90C3-7AD3-4270-BD76-B5315BB4FB7CQ49927452-23287309-509A-449E-9290-880F1B57B805Q50183988-856A37B5-E2F1-4935-8239-800459CF21EBQ53892628-B9E5BD7D-5EA4-4717-A92F-5EE4FD6BBFEFQ55325337-D49E30A3-837E-4C19-B025-A746068C3BA3Q58599093-017EABF8-560A-4529-A283-F968CBAF385EQ59746519-3A0EC2A7-8A3E-4299-BF1B-D265E36A6E51Q60041093-E5587256-0A32-473F-AC41-FA2F9228940DQ71706133-7A917FF0-EF14-4434-A7AB-647FF5D33ABAQ78858556-63406A32-950A-4816-97CD-D15C1C751182Q90188989-106F741A-82A1-43CD-A0F9-DA7BFD14B09E
P50
description
neuroloog
@nl
researcher ORCID ID = 0000-0003-2164-7842
@en
name
Tim von Oertzen
@ast
Tim von Oertzen
@de
Tim von Oertzen
@en
Tim von Oertzen
@es
Tim von Oertzen
@nl
type
label
Tim von Oertzen
@ast
Tim von Oertzen
@de
Tim von Oertzen
@en
Tim von Oertzen
@es
Tim von Oertzen
@nl
prefLabel
Tim von Oertzen
@ast
Tim von Oertzen
@de
Tim von Oertzen
@en
Tim von Oertzen
@es
Tim von Oertzen
@nl
P227
P21
P214
3700153289886632770005
P227
1163482609
P31
P496
0000-0003-2164-7842
P734
P7859
viaf-3700153289886632770005